4,5-Dicaffeoylquinic acid
Based on 12 publication(s) in Google Scholar
4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) is an antioxidant, can be isolated from Gynura divaricata and Laggera alata. 4,5-Dicaffeoylquinic acid reduces islet cell apoptosis and improves pancreatic function in type 2 diabetic mice, and has obvious inhibitory activities against yeast α-glucosidase. 4,5-Dicaffeoylquinic acid inhibits prostate cancer cells through cell cycle arrest. 4,5-Dicaffeoylquinic acid also has anti-apoptotic, anti-injury and anti-hepatitis B virus effects.
For research use only. We do not sell to patients.
- Purity: 99.83%
- CAS No.: 57378-72-0
- Formula: C25H24O12
- Molecular Weight:516.45
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) 4,5-Dicaffeoylquinic acid
More- Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
- Phytomedicine. 2026 Feb:151:157776. [Abstract]
- Int J Biol Macromol. 2025 Mar:294:139536. [Abstract]
- J Agric Food Chem. 2021 Aug 18;69(32):9270-9286. [Abstract]
- J Agric Food Chem. 2019 Nov 6;67(44):12303-12312. [Abstract]
- Cell Biosci. 2023 Nov 14;13(1):210. [Abstract]
- Foods. 2024 Apr 3;13(7):1101. [Abstract]
- ACS Omega. 2025 Sep 22;10(38):44260-44269. [Abstract]
- Vet Microbiol. 2026 May:316:110992. [Abstract]
- Biologia. (2019) 74:1569-1577.
- SSRN. 2026 Apr 8.
- Chemistry of Plant Raw Material. 2025.
-
WB
-
WB
-
IP
-
Cell Imaging/Staining
-
IHC
All Endogenous Metabolite Isoforms
More
Biological Activity
4,5-Dicaffeoylquinic acid (0.1~100 μM; 72 h) has dose-dependent inhibitory activity against DU-145 prostate cancer cells, and induces cell cycle arrest, also induces inactivation of Bcl-2[2].
4,5-Dicaffeoylquinic acid (1~100 μg/mL; 48 h) has anti-apoptotic effect in D-GalN-challenged HL-7702 hepatocytes, and improves significantly cell viability at concentrations of 10 to 100 μg/mL[3].
4,5-Dicaffeoylquinic acid (1~100 μg/mL; 4 days) inhibits significantly expressions of HBsAg and HBeAg, and produces the maximum inhibition rates of 86.93 and 59.79% at 100 μg/mL on expressions of HBsAg and HBeAg, respectively[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:DU-145 cells
-
Concentration:0.1~100 µM
-
Incubation Time:72 h
-
Result:Exhibits dose-dependent inhibitory activity against DU-145 prostate cancer cells with an IC50 of 5 µM.
-
Cell Line:DU-145 cells
-
Concentration:5 µM
-
Incubation Time:72 h
-
Result:Decreased in numbers in G0/G1 phase and increased in S phase.
-
Cell Line:HL-7702 hepatocytes (exposure to 60 mM D-GalN for 6h)
-
Concentration:1~100 μg/mL
-
Incubation Time:48 h
-
Result:Significantly reduced the caspase-3 and transforming growth factor β1 (TGFβ1) levels of the D-GalN-challenged hepatocytes at 10~100 µg/mL.
-
Cell Line:HL-7702 hepatocytes (exposure to 80 mM D-GalN for 6h)
-
Concentration:1~100 μg/mL
-
Incubation Time:48 h
-
Result:Improved significantly cell viability at concentrations of 10 to 100 µg/mL, and produced a maximum protection rate of 47.28% at 100 µg/mL.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 57378-72-0
-
Appearance Solid
-
Molecular Weight 516.45
-
Formula C25H24O12
-
Color White to light yellow
-
SMILES
O=C([C@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@@H](OC(/C=C/C3=CC=C(O)C(O)=C3)=O)[C@H](O)C1)O
-
Synonyms
Isochlorogenic acid C; 4,5-diCQA
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
Dipeptidyl Peptidase 4 (DPP4) Exacerbates Osteoarthritis Progression in an Enzyme-Independent Manner. [Abstract]2025 Feb;12(6):e2410525. PMID: 39680708
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
Different concentrations of 4,5-diCQA (4,5-Dicaffeoylquinic acid, 0-20 μM) were added to C28/I2 cells, and MYH9 levels were analyzed by western blot (n = 3 independent biological replicates).
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
Different concentrations of 4,5-diCQA (4,5-Dicaffeoylquinic acid, 0-20 μM) were added to DPP4-overexpressing C28/I2 cells, and MYH9 levels were analyzed by western blot (n = 3 independent biological replicates).
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
In C28/I2 cells transfected with MYH9-FLAG and DPP4‐HA plasmids, the addition of 4,5-diCQA (4,5-Dicaffeoylquinic acid), followed by IP pull-down of MYH9-FLAG and western blot analysis to detect DPP4‐HA levels (n = 3 independent biological replicates).
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
C28/I2 cells were treated with or without 4,5‐diCQA (4,5-Dicaffeoylquinic acid), and the interaction between DPP4 and MYH9 was analyzed using PLA.
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
IHC analysis of knee joints from Sham, DMM+PBS, and DMM+4,5-diCQA (4,5-Dicaffeoylquinic acid) groups.
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
Micro-CT analysis of knee joints from Sham, DMM+PBS, and DMM+4,5-diCQA (4,5-Dicaffeoylquinic acid) groups, including quantitative analysis of osteophyte number and SBP thickness.
4,5-Dicaffeoylquinic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Feb;12(6):e2410525. [Abstract]
Schematic diagram of the experimental design: 10-week-old mice underwent Sham or DMM surgery. One week after surgery, the DMM group received weekly intra-articular injections of PBS or 4,5-diCQA (4,5-Dicaffeoylquinic acid) until 8 weeks after surgery, when knee joints were collected. Schematic diagram of the experimental design: 18-month-old mice received intra-articular injections of AAV2-NC, AAV2-Dpp4-WT, or AAV2-Dpp4-MUT. Two weeks later, AAV2-NC mice received weekly PBS injections, while AAV2-Dpp4-WT and AAV2-Dpp4-MUT mice received weekly 4,5-diCQA injections. Knee joints were collected 3 months later.
-
Phytomedicine
A novel mechanism of Reduning injection in sepsis treatment: Targeting inflammatory kinases TBK1 and IKKβ. [Abstract]2026 Feb:151:157776. PMID: 41512388 -
Int J Biol Macromol
2025 Mar:294:139536. PMID: 39765299 -
J Agric Food Chem
Raw and Sous-Vide-Cooked Red Cardoon Stalks ( Cynara cardunculus L. var. altilis DC): (Poly)phenol Bioaccessibility, Anti-inflammatory Activity in the Gastrointestinal Tract, and Prebiotic Activity. [Abstract]2021 Aug 18;69(32):9270-9286. PMID: 34347467 -
J Agric Food Chem
Isolation, Identification, and Synthesis of a New Prenylated Cinnamic Acid Derivative from Brazilian Green Propolis and Simultaneous Quantification of Bioactive Components by LC-MS/MS. [Abstract]2019 Nov 6;67(44):12303-12312. PMID: 31597041 -
Cell Biosci
2023 Nov 14;13(1):210. PMID: 37964389 -
Foods
Effects of Cooking Methods on Caffeoylquinic Acids and Radical Scavenging Activity of Sweet Potato. [Abstract]2024 Apr 3;13(7):1101. PMID: 38611405 -
ACS Omega
Selective Enhancement of Caffeoylquinic Acid Derivative via UV Irradiation and Validation of Analytical Method in the Aerial Aster × chusanensis Y. S. Lim. [Abstract]2025 Sep 22;10(38):44260-44269. PMID: 41048756 -
Vet Microbiol
The Chinese medicine monomer Schisandrin C inhibits PRRSV infection by regulating the OGT-PI3K/AKT/mTOR signaling pathway. [Abstract]2026 May:316:110992. PMID: 41865607 -
-
-
Solvent & Solubility
DMSO : 100 mg/mL (193.63 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.84 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.84 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (283 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Yin XL, et al. Gynura divaricata rich in 3, 5-/4, 5-dicaffeoylquinic acid and chlorogenic acid reduces islet cell apoptosis and improves pancreatic function in type 2 diabetic mice. Nutr Metab (Lond). 2018 Oct 10;15:73. [Content Brief]
[2]. Lodise O, et al. Inhibition of Prostate Cancer Cells by 4,5-Dicaffeoylquinic Acid through Cell Cycle Arrest. Prostate Cancer. 2019 May 23;2019:4520645. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9363 mL | 9.6815 mL | 19.3630 mL | 48.4074 mL |
| 5 mM | 0.3873 mL | 1.9363 mL | 3.8726 mL | 9.6815 mL | |
| 10 mM | 0.1936 mL | 0.9681 mL | 1.9363 mL | 4.8407 mL | |
| 15 mM | 0.1291 mL | 0.6454 mL | 1.2909 mL | 3.2272 mL | |
| 20 mM | 0.0968 mL | 0.4841 mL | 0.9681 mL | 2.4204 mL | |
| 25 mM | 0.0775 mL | 0.3873 mL | 0.7745 mL | 1.9363 mL | |
| 30 mM | 0.0645 mL | 0.3227 mL | 0.6454 mL | 1.6136 mL | |
| 40 mM | 0.0484 mL | 0.2420 mL | 0.4841 mL | 1.2102 mL | |
| 50 mM | 0.0387 mL | 0.1936 mL | 0.3873 mL | 0.9681 mL | |
| 60 mM | 0.0323 mL | 0.1614 mL | 0.3227 mL | 0.8068 mL | |
| 80 mM | 0.0242 mL | 0.1210 mL | 0.2420 mL | 0.6051 mL | |
| 100 mM | 0.0194 mL | 0.0968 mL | 0.1936 mL | 0.4841 mL |